Showing results (101-110 of 105) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
The Lancet. Oncology|April 7, 2022
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trialYann-Alexandre Vano, Réza Elaidi, Mostefa Bennamoun, et al.Biorxiv : the Preprint Server for Biology|January 7, 2025
Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancerRaphaël Mattiuz, Jesse Boumelha, Pauline Hamon, et al.Nature Cancer|February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcomaChristina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.Nature|January 17, 2020
B cells and tertiary lymphoid structures promote immunotherapy responseBeth A Helmink, Sangeetha M Reddy, Jianjun Gao, et al.Science (New York, N.Y.)|July 16, 2026
Dendritic cells control tertiary lymphoid structure development and maintenance in cancerRaphaël Mattiuz, Jesse Boumelha, Emmanouil Aerakis, et al.Pageof 11